Patient Handling Articles & Analysis: Older
-
OSHA Announces New Hazards for the Healthcare Industry
Last month, OSHA announced that agency investigators would increase their focus on a set of new key hazards for the healthcare industry during upcoming inspections. These hazards will aim to address musculoskeletal disorders related to patient or resident handling; blood borne pathogens; workplace violence; tuberculosis and slips, trips and falls. To those in the healthcare industry, this ...
-
Segmed Ethics Committee Recap
Anonymized medical data sharing is necessary for the advancement of medicine, but it requires a tremendous amount of trust from all stakeholders. Patients need to trust that their healthcare providers are utilizing their data to advance innovations that will help them in the future. Healthcare providers such as health systems and hospitals must trust external stakeholders to use that data for ...
By Segmed, Inc.
-
Open hospital event in Koege with PTR Robot demonstrations
Sunday 5th September our PTR Robot was featured on Danish TV, about the robot being deployed at the new hospital, Region Sealand University Hospital Koege. To see video, please click here The public was invited to an open hospital event in Koege at the Region Zealand University Hospital. The 600 million euro development project includes a brand new 140.000 m2 hospital building with 789 single ...
-
Welcome T2
A complete redesign of the T-Stat was launched in 2020. New features included a sleek and strong exterior of powder coated metal, framed with a soft plastic bumper to prevent any damage in the hospital environment. Battery back-up was added to make patient ambulation and transfer seemless and without any interruption in patient data. WiFi access has been added to accommodate hospitals and labs ...
-
Artificial intelligence and usability testing of the PTR Robot
We are delighted to highlight two studies produced by the Blue Ocean Robotics team together with our product specialist, Britta Geleijns. These studies are based on the development and testing of the PTR Robot. Both presentations will be presented at the IROS 2021 conference, International Conference on Intelligent Robots and Systems. Developing Ethical AI-Supported Healthcare Robots The former ...
-
Injection of capital to accelerate global expansion
In a world with increasing labor shortages and a growing ageing population, demand for service robots that can assist companies and institutions is growing. This is why Blue Ocean Robotics, Europe’s largest manufacturer of service robots, has now strengthened its financial muscle, enabling the company to roll out its sustainable mobile robot solutions all over the world. Service robots are ...
-
World Humanitarian Day, 19th August 2015
World Humanitarian Day, 19th August 2015 19th August marks World Humanitarian Day. This year people are donating their social media newsfeeds to give a voice to the voiceless. Read and share these 6 compelling stories of incredible resilience, courage and survival. Baby in the Rubble: Syria’s White Helmets Khaled Farah is a first responder for the White Helmets in Syria’s ...
-
BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TVT 2019
BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the Annual Transcatheter Valve Therapy Structural Heart Summit (TVT 2019), which will take place June 12-15 at the Sheraton Grand Chicago. The company’s Tempo Temporary Pacing Lead will be featured in a symposium titled “Improving Safety & Reducing ...
-
Turning a Great Idea into a Successful Product: ASPIRE
For VisionQuest’s vice president and principal investigator Vinayak Joshi (PhD), the journey from idea to commercial product has led him halfway around the world. Dr. Joshi recently traveled to Malawi, Kenya, Nigeria, and Ghana as part of his efforts to commercialize ASPIRE, his device for the detection and diagnosis of malarial retinopathy. While in Africa, he met with leaders in ...
-
BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing
BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s Tempo Lead has obtained CE Mark certification in Europe for use in cardiac procedures requiring temporary intracardiac pacing. BioTrace Medical’s Tempo Temporary Pacing Lead is designed for safer, more secure and stable pacing to reduce intraprocedural complications, ...
-
Think Porthole: Challenges to imaging the heart with ultrasound
There is no doubt that 2-dimensional (2D) ultrasound imaging can be a challenging task to learn. Performing ultrasound requires some imagination. A simple turn of the transducer can change the orientation of anatomy. Therefore, learning anatomy in this way is not always straightforward as with 3-dimensional fixed images. To further complicate matters, the human body presents obstacles at nearly ...
-
National Institute for Health and Care Excellence (NICE) Publishes Briefing on ReStore Soft Exo-Suit in the UK
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced its ReStore Soft Exo-Suit was the subject of a recent Medtech Innovation Briefing (MIB) by the UK's National Institute for Health and Care Excellence (NICE). These briefings are designed to support National Health Services (NHS) ...
-
AcuPebble SA100 offers automated sleep apnea diagnosis equivalent to cardiorespiratory polygraphy
AcuPebble SA100 is clinically equivalent to cardiorespiratory polygraphy for the automated diagnosis of obstructive sleep apnea (OSA) at home, a paper published in the BMJ Open has revealed. A powered clinical trial conducted by the Royal Free Hospital in London demonstrated both the accuracy and usability of the small device, which has the potential to open more efficient patient pathways for ...
-
Terumo Aortic Announces US FDA Approval for Thoraflex Hybrid
Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted approval of the Thoraflex Hybrid Frozen Elephant Trunk (FET) device for commercial sale in the United States for the treatment of patients with complex aortic arch disease. Thoraflex Hybrid is the first of its kind device used in Frozen Elephant Trunk (FET) repair in the United States and was granted ...
-
IAQ and Infection Control Professionals Play a Critical Role in Preventing HAIs
The Telegraph reported last week about the risk of infection to hospital patients due to exposure to pillows that may be contaminated with a host of microbial pathogens. The article discusses a new study conducted by The Barts and The London NHS Trust that found 30 different types of possible infections in pillows taken from hospital wards. Potential exposure to C. diff and MRSA were just a few ...
-
Clostridium difficile: A Healthcare & Community Acquired Infection
Clostridium difficile, also known as C. diff, CDI and C. difficile, is a bacterium that may develop due to the prolonged use of antibiotics during healthcare treatment. C. diff infections cause diarrhea and more serious intestinal conditions such as colitis. It is a major culprit for healthcare associated infections (HAIs) and has been increasingly identified as a community acquired infection. ...
-
SeqOne Genomics and the French Thrombotic MicroAngiopathies National reference center (CNR-MAT) pioneer the use of Oxford Nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times
SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving the diagnosis and management of patients suspected of suffering from thrombotic microangiopathies and atypical Hemolytic syndrome (aHUS). The program involved using Oxford Nanopore’s ...
-
PsiOxus to Present Positive Biomarker Data at ESMO 2021 Demonstrating the Potential of Their Novel Tumor-Selective T-SIGn vector, NG-350A, to Re-Engineer Advanced Cancers
Key data from the first-in-human FORTITUDE trial shows that a single cycle of intravenous (IV) NG-350A drives dose-dependent increases in specific inflammatory biomarkers, consistent with the mechanism of the encoded anti- CD40 agonist. IV dosing of NG-350A led to elevations in IL-12, IFNγ and IL-17 that were higher and sustained for longer than those reported for systemic CD40 agonists. ...
-
Babson Diagnostics, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings
Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing. Since 2019, the two companies ...
-
miR Scientific to Present the Prostate Cancer Application of its Liquid Biopsy miR Disease Management Platform® at the 12th Annual Prostate Cancer Awareness Day (PCAD) at the Massachusetts State House
NEW YORK, Feb. 25, 2021 /PRNewswire/ -- miR Scientific, LLC, a healthcare company whose purpose is to transform global cancer management by providing early and highly accurate detection, characterization and monitoring of disease, announced today that its Chairman & CEO, Sam Salman, will be virtually presenting at the 12th Annual Prostate Cancer Awareness Day at the Massachusetts State House ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you